clinic
entiti
atyp
pneumonia
recogn
mani
year
etiolog
agent
establish
mccoy
term
separ
entiti
pneumonia
classic
pneumococc
pneumonia
due
lack
respons
avail
antibiot
distinct
clinic
present
without
typic
lobar
pneumonia
less
sever
diseas
cours
term
walk
pneumonia
introduc
denot
mild
form
pneumonia
patient
atyp
pneumonia
mycoplasma
pneumonia
first
isol
sputum
tissu
cultur
eaton
et
al
time
believ
viru
resist
penicillin
sulfonamid
pass
bacteriaretain
filter
experi
marin
recruit
adult
prison
demonstr
socal
eaton
agent
caus
lower
respiratori
tract
infect
human
chanock
et
al
b
first
cultur
cellfre
medium
classifi
pneumonia
chanock
et
al
chanock
today
know
mycoplasma
prokaryot
lack
cell
wall
repres
smallest
selfrepl
organ
figur
size
base
pair
genom
pneumonia
least
five
time
smaller
escherichia
coli
himmelreich
et
al
absenc
cell
wall
special
attach
organel
facilit
close
contact
host
respiratori
epithelium
suppli
bacterium
necessari
nutrient
growth
prolifer
mycoplasma
pneumonia
caus
upper
lower
respiratori
tract
infect
communityacquir
pneumonia
cap
major
burden
diseas
although
pneumonia
infect
gener
mild
selflimit
patient
everi
age
develop
sever
fulmin
diseas
kannan
et
al
pneumonia
also
caus
extrapulmonari
manifest
affect
almost
everi
organ
narita
children
pneumonia
infect
first
report
children
lower
respiratori
tract
diseas
test
posit
fourfold
rise
antibodi
titer
eaton
agent
chanock
et
al
date
known
incid
pneumonia
infect
gener
higher
children
adult
foy
et
al
review
focus
characterist
pneumonia
infect
children
discuss
simpl
clinic
decis
rule
may
aid
clinician
identifi
patient
high
risk
pneumonia
cap
mycoplasma
pneumonia
transmit
respiratori
droplet
close
contact
incub
period
long
week
outbreak
report
within
famili
school
univers
institut
camp
militari
base
famili
member
index
patient
acut
respiratori
infect
detect
pneumonia
upper
respiratori
tract
found
posit
polymeras
chain
reaction
pcr
dorigozetsma
et
al
thereof
year
age
develop
respiratori
symptom
univers
largest
outbreak
within
year
us
observ
septemb
total
cap
case
identifi
among
student
test
case
posit
pneumonia
quantit
realtim
pcr
center
diseas
control
prevent
cdc
outbreak
appear
mainli
pneumonia
epidem
occur
year
cycl
addit
background
endem
pattern
jacob
recent
epidem
europ
occur
peak
incid
finland
case
polkowska
et
al
jacob
et
al
cyclic
occurr
epidem
may
facilit
decreas
herd
immun
differ
pneumonia
genotyp
circul
human
popul
jacob
two
major
circul
genotyp
subtyp
pneumonia
indic
subtyp
differ
subtyp
amino
acid
sequenc
major
adhes
protein
believ
play
role
epidemiolog
infect
pneumonia
su
et
al
vink
et
al
differ
protein
subtyp
isol
found
concentr
two
specif
amino
acid
stretch
within
protein
region
encod
two
dna
element
within
gene
ie
repetit
element
uniqu
gene
also
found
site
within
bacteri
genom
spuesen
et
al
homolog
recombin
event
repetit
element
similar
ident
may
form
basi
antigen
variat
protein
pneumonia
vink
et
al
recombin
event
may
induc
antigen
variat
within
subtyp
subtyp
strain
pneumonia
strain
switch
one
subtyp
entir
set
repmp
element
found
one
subtyp
differ
significantli
found
subtyp
moreov
chang
proport
two
subtyp
pneumonia
observ
europ
jacob
et
al
although
cap
major
burden
diseas
milder
clinic
present
pneumonia
respiratori
infect
may
much
common
cap
includ
acut
bronchiti
upper
respiratori
tract
infect
esposito
et
al
pneumonia
could
detect
pcr
andor
serolog
nonstreptococc
pharyng
case
esposito
et
al
estim
children
pneumonia
respiratori
infect
develop
cap
cap
case
sever
enough
requir
hospit
wait
talkington
pneumonia
detect
cultur
respiratori
specimen
andor
fourfold
titer
rise
complement
fixat
test
cft
radiolog
confirm
cap
case
seattl
us
foy
et
al
subsequ
etiolog
studi
pneumonia
account
isol
identifi
pcr
andor
serolog
children
cap
admit
hospit
juven
et
al
principi
et
al
baer
et
al
michelow
et
al
pneumonia
first
report
common
bacteri
caus
cap
children
requir
hospit
us
multicent
studi
nashvil
salt
lake
citi
jain
et
al
studi
pneumonia
could
detect
pcr
case
cap
wherea
streptococcu
pneumonia
found
case
manifest
upper
andor
lower
respiratori
tract
infect
pneumonia
occur
age
foy
et
al
recent
observ
indic
pneumonia
also
rel
high
preval
respiratori
tract
children
year
principi
et
al
gadsbi
et
al
pneumonia
cap
howev
report
frequent
among
schoolag
children
year
age
declin
adolesc
taper
adulthood
figur
foy
et
al
notion
corrobor
recent
cap
studi
us
pneumonia
detect
significantli
frequent
children
year
age
younger
children
vs
jain
et
al
addit
present
schoolag
children
cap
due
pneumonia
found
present
significantli
longer
durat
fever
compar
children
cap
fischer
et
al
symptom
may
associ
pneumonia
cap
absenc
wheez
presenc
chest
pain
wang
et
al
howev
still
pauciti
high
qualiti
data
regard
clinic
sign
symptom
associ
pneumonia
infect
recent
cochran
review
therefor
conclud
absenc
presenc
individu
clinic
symptom
sign
use
help
clinician
accur
diagnos
pneumonia
children
adolesc
cap
wang
et
al
pathogen
effect
respiratori
tract
may
caus
pneumonia
either
directli
activ
infect
indirectli
infectioninduc
immun
mechan
narita
pneumonia
caus
direct
injuri
gener
activ
oxygen
potenti
candid
protein
pneumonia
may
involv
caus
direct
damag
respiratori
tract
pertussi
toxinlik
protein
term
communityacquir
respiratori
distress
syndrom
card
toxin
kannan
baseman
becker
et
al
recombin
version
card
toxin
shown
bind
high
affin
surfact
protein
exhibit
monoadp
ribosyltransferas
vacuol
activ
caus
disrupt
respiratori
epithelium
anim
model
kannan
baseman
addit
direct
damag
result
infect
pneumonia
immunolog
respons
follow
infect
gener
inflammatori
reaction
may
caus
pulmonari
extrapulmonari
symptom
sever
symptom
cap
observ
older
children
adolesc
wait
talkington
suggest
agedepend
magnitud
natur
inflammatori
respons
childhood
may
major
factor
contribut
develop
pneumoniaeassoci
diseas
similar
observ
eg
infecti
mononucleosi
rheumat
fever
fact
sever
pneumonia
cap
children
close
associ
increas
concentr
interleukin
il
acut
phase
serum
pleural
fluid
sampl
narita
tanaka
addit
demonstr
cellmedi
immun
contribut
pathogenesi
pneumonia
cap
shown
sever
cap
correl
posit
size
cutan
indur
follow
intraderm
inject
pneumonia
antigen
mizutani
et
al
studi
describ
patient
cap
children
year
age
diagnos
signific
rise
antibodi
titer
pneumonia
cft
strongest
skin
reaction
seen
patient
sever
cap
mycoplasma
pneumonia
atyp
bacteria
long
implic
pathogenesi
asthma
atkinson
mani
studi
address
issu
recent
past
observ
studi
children
adult
asthma
pneumonia
infect
diagnos
children
asthma
found
frequent
patient
chronic
asthma
asthma
exacerb
p
bebear
et
al
diagnosi
pneumonia
infect
studi
perform
pcr
andor
serolog
anoth
recent
studi
diagnos
pneumonia
children
acut
asthma
refractori
asthma
well
healthi
control
find
signific
differ
three
group
wood
et
al
high
detect
rate
report
studi
obtain
use
novel
diagnost
method
card
toxin
enzym
immunoassay
eia
card
genespecif
pcr
wood
et
al
recent
taiwanes
studi
yeh
et
al
children
adult
pneumonia
infect
diagnos
posit
immunoglobulin
ig
fourfold
igg
titer
increas
without
prior
asthma
histori
includ
follow
diagnosi
asthma
end
compar
match
patient
without
pneumonia
infect
cumul
incid
asthma
significantli
higher
pneumonia
cohort
control
cohort
p
patient
pneumonia
infect
higher
risk
earlyonset
asthma
age
asthma
diagnosi
year
lateonset
asthma
age
asthma
diagnosi
year
recent
find
suggest
pneumonia
induc
airway
inflamm
contribut
incid
asthma
interestingli
exposur
recombin
card
toxin
result
allergictyp
inflammatori
respons
airway
hyperreact
mice
baboon
hardi
et
al
medina
et
al
interest
investig
whether
card
toxin
induc
similar
allerg
respons
pneumonia
infect
apart
respiratori
tract
infect
pneumonia
caus
extrapulmonari
manifest
almost
everi
organ
includ
skin
hematolog
cardiovascular
musculoskelet
nervou
system
narita
manifest
may
caus
either
direct
local
effect
pneumonia
dissemin
bacteria
throughout
bodi
indirect
effect
autoimmun
reaction
frequent
manifest
diseas
dermatolog
nervou
system
skin
manifest
occur
pneumonia
infect
includ
mostli
nonspecif
exanthem
erythema
nodosum
urticaria
syndrom
rare
distinct
disord
promin
mucou
membran
involv
denomin
pneumoniaeassoci
mucos
mpam
schalock
dinulo
meyer
sauteur
et
al
condit
first
describ
fuch
therefor
also
refer
fuch
syndrom
meyer
sauteur
et
al
recent
review
identifi
patient
mpam
median
age
year
present
rang
year
children
young
adolesc
year
meyer
sauteur
et
al
patient
present
prodrom
respiratori
symptom
median
durat
day
pneumonia
found
chest
radiographi
oral
lesion
present
case
figur
ocular
lesion
urogenit
lesion
skin
lesion
although
patient
admit
intens
care
unit
one
suffer
longterm
sequela
enceph
syndrom
gb
constitut
common
sever
neurolog
manifest
pneumonia
infect
establish
patient
respect
bitnun
et
al
sinha
et
al
pneumoniaeassoci
enceph
direct
infect
central
nervou
system
cn
immunemedi
process
impli
involv
narita
detect
rate
pneumonia
pcr
cerebrospin
fluid
csf
pneumonia
enceph
patient
rel
low
bitnun
et
al
daxboeck
et
al
christi
et
al
domenech
et
al
signific
proport
case
believ
immunemedi
support
find
variou
case
pneumonia
enceph
bacteri
dna
could
detect
csf
prolong
durat
respiratori
symptom
onset
enceph
day
bitnun
et
al
narita
yamada
daxboeck
et
al
case
indic
pneumonia
enceph
repres
postinfecti
disord
manifest
clearanc
bacteria
cn
respiratori
tract
immun
system
meyer
sauteur
et
al
recent
studi
present
children
pneumonia
detect
respiratori
tract
csf
pcr
enceph
toronto
canada
alzaidi
et
al
interestingli
patient
pneumonia
detect
respiratori
tract
csf
show
pulmonari
infiltr
chest
radiograph
frequent
patient
posit
pcr
csf
vs
suggest
pneumonia
may
indic
remot
inflammatori
process
pneumonia
enceph
patient
also
shown
children
observ
nation
surveil
neg
pcr
csf
switzerland
meyer
sauteur
et
al
figur
mycoplasma
pneumonia
express
adhes
protein
glycolipid
share
structur
homolog
varieti
host
cell
molecular
mimicri
may
induc
crossreact
antibodi
meyer
sauteur
et
al
children
pneumonia
enceph
intrathec
antibodi
direct
galactocerebrosid
galc
found
christi
et
al
meyer
sauteur
et
al
note
patient
neg
pcr
csf
galc
major
glycolipid
antigen
myelin
sheath
peripher
cn
neuron
meng
et
al
fact
antibodi
pneumonia
infect
found
crossreact
galc
gb
patient
kusunoki
et
al
ang
et
al
moreov
antigalc
antibodi
caus
demyelin
neuropathi
rabbit
saida
et
al
associ
demyelin
gb
ang
et
al
also
enceph
christi
et
al
encephalomyel
samukawa
et
al
detect
intrathec
antibodi
pneumonia
galc
may
also
regard
promis
new
diagnost
tool
pneumoniaeassoci
cn
diseas
meyer
sauteur
et
al
like
mani
respiratori
pathogen
pneumonia
carri
asymptomat
respiratori
tract
foy
recent
studi
demonstr
asymptomat
carriag
pneumonia
highli
preval
detect
rate
pneumonia
dna
respiratori
tract
healthi
children
without
respiratori
symptom
dutch
studi
rotterdam
netherland
spuesen
et
al
us
studi
san
antonio
tx
us
wood
et
al
longitudin
sampl
asymptomat
children
demonstr
pneumonia
present
upper
respiratori
tract
without
caus
diseas
month
spuesen
et
al
preval
pneumonia
upper
respiratori
tract
asymptomat
children
vari
consider
year
season
exampl
asymptomat
carriag
rate
report
spring
summer
respect
spuesen
et
al
data
suggest
carriag
follow
epidem
pattern
tempt
specul
fluctuat
preval
relat
cyclic
epidem
pneumonia
infect
apart
pneumonia
children
found
simultan
carri
mani
pathogen
nose
throat
spuesen
et
al
pathogen
includ
bacteria
pneumonia
staphylococcu
aureu
moraxella
catarrhali
haemophilu
influenza
virus
influenza
ab
human
metapneumoviru
respiratori
syncyti
viru
parainfluenzaviru
rhinoviru
coronaviru
bocaviru
adenoviru
simultan
presenc
two
pathogen
detect
asymptomat
children
spuesen
et
al
children
pneumonia
cap
coexist
pneumonia
pathogen
also
describ
juven
et
al
michelow
et
al
recent
report
patient
jain
et
al
impact
coinfect
pneumonia
cap
diseas
sever
yet
determin
mere
presenc
pneumonia
upper
respiratori
tract
neither
indic
predict
respiratori
diseas
routin
diagnost
procedur
detect
acut
respiratori
infect
pneumonia
need
reconsid
overview
diagnost
test
advantag
drawback
shown
tabl
current
guidelin
bradley
et
al
harri
et
al
recommend
pcr
singlesampl
serolog
test
diagnos
pneumonia
infect
sensit
serolog
test
depend
time
point
first
serum
avail
pair
sera
seroconvers
igg
andor
rise
antibodi
titer
specif
serum
igm
emerg
within
week
initi
infect
week
igg
meyer
sauteur
et
al
although
specif
serum
iga
aris
even
earlier
igm
could
detect
pcrposit
children
symptomat
respiratori
tract
infect
spuesen
et
al
crossreact
pathogen
noninfecti
diseas
describ
cft
particl
agglutin
assay
also
eia
lack
requir
sensit
specif
beersma
et
al
intrigu
detect
igm
well
igg
iga
eia
could
discrimin
asymptomat
symptomat
group
children
spuesen
et
al
demonstr
posit
serolog
result
asymptomat
pneumonia
pcrposit
children
n
igm
igg
iga
may
simpli
reflect
one
previou
encount
pneumonia
necessarili
relat
presenc
pneumonia
respiratori
tract
thu
question
whether
posit
result
test
actual
indic
etiolog
role
pneumonia
case
sens
posit
predict
valu
test
may
overestim
wherea
neg
predict
valu
may
accept
bradley
et
al
gold
standard
diagnosi
pneumonia
infect
still
consid
fourfold
increas
antibodi
titer
measur
pair
sera
gardin
et
al
howev
use
convalesc
sera
use
clinic
practic
timeconsum
allow
clinician
initi
treatment
protocol
time
fashion
clinician
therefor
need
awar
implic
clinic
signific
posit
pcr
serolog
test
result
diagnost
test
may
reliabl
predict
symptomat
pneumonia
infect
clinic
assess
entiti
revisit
british
thorac
societi
guidelin
recommend
bacteri
pneumonia
consid
children
persist
repetit
fever
togeth
chest
recess
rais
respiratori
rate
harri
et
al
chest
radiograph
consid
routin
investig
children
thought
cap
fact
although
bilater
diffus
infiltr
common
none
radiograph
find
associ
pneumonia
cap
specif
john
et
al
fastandfrug
clinic
decis
tree
provid
rapid
probabl
estim
caus
cap
children
year
zurich
switzerland
fischer
et
al
pneumonia
infect
diagnos
n
children
pcr
respiratori
specimen
serolog
seroconvers
andor
fourfold
rise
antibodi
titer
compar
children
cap
patient
pneumonia
older
longer
durat
fever
p
ask
simpl
question
regard
age
child
durat
fever
allow
identif
follow
group
high
risk
cap
due
pneumonia
children
cap
fever
day
year
age
score
model
place
patient
pneumonia
infect
highrisk
group
figur
simpl
rule
may
aid
physician
prescrib
appropri
firstlin
antibiot
consequ
diagnost
uncertainti
pneumonia
infect
british
thorac
societi
guidelin
suggest
empir
macrolid
treatment
age
respons
firstlin
antibiot
case
sever
diseas
harri
et
al
lack
cell
wall
make
pneumonia
resist
cell
wall
synthesi
inhibitor
antibiot
antibiot
best
minimum
inhibitori
concentr
valu
pneumonia
includ
macrolid
tetracyclin
fluoroquinolon
wait
talkington
although
latter
two
good
vitro
inhibitori
effect
pneumonia
tetracyclin
may
caus
teeth
discolor
wait
talkington
fluoroquinolon
may
affect
develop
cartilag
young
children
adefurin
et
al
thu
recommend
current
guidelin
young
children
age
limit
tetracyclin
year
fluoroquinolon
adolesc
skelet
matur
bradley
et
al
occurr
arthropathi
due
fluoroquinolon
howev
uncertain
musculoskelet
advers
effect
report
literatur
revers
follow
withdraw
treatment
adefurin
et
al
protein
synthesi
inhibitor
macrolid
class
favor
side
effect
profil
therefor
firstlin
antibiot
pneumonia
infect
children
bradley
et
al
although
antibiot
effect
pneumonia
vitro
bebear
et
al
lack
evid
vivo
efficaci
observ
data
indic
children
cap
due
pneumonia
shorter
durat
symptom
fewer
relaps
treat
antimicrobi
agent
activ
pneumonia
mccracken
wait
talkington
recent
cochran
review
evalu
seven
studi
effect
antibiot
treatment
pneumonia
lower
respiratori
tract
infect
children
gardin
et
al
howev
diagnost
criteria
type
durat
treatment
inclus
criteria
outcom
measur
differ
significantli
make
difficult
draw
specif
conclus
although
one
trial
suggest
macrolid
may
efficaci
case
esposito
et
al
clear
studi
efficaci
antibiot
reli
correct
diagnosi
pneumonia
infect
given
aforement
shortcom
current
diagnost
test
conclus
efficaci
antibiot
treatment
reexamin
sinc
extens
macrolid
use
led
alarm
worldwid
increas
preval
macrolideresist
pneumonia
mrmp
strain
bebear
et
al
resist
base
specif
point
mutat
domain
v
rrna
posit
reduc
affin
macrolid
larg
subunit
bacteri
ribosom
bebear
et
al
mrmp
observ
macrolid
treatment
result
antibiot
select
pressur
cardinal
et
al
chironna
et
al
saegeman
et
al
date
macrolid
resist
detect
worldwid
scale
mrmp
develop
asia
hong
et
al
mrmp
rate
risen
high
china
zhao
et
al
mrmp
also
report
north
america
europ
figur
clinic
relev
macrolid
resist
hospit
children
cap
may
lie
prolong
symptom
diseas
okada
et
al
cardinal
et
al
zhou
et
al
zhou
et
al
found
increas
mrmp
may
also
seriou
clinic
consequ
children
lead
sever
radiolog
find
cap
even
increas
extrapulmonari
manifest
studi
hospit
children
cap
due
mrmp
develop
often
extrapulmonari
diseas
children
cap
caus
macrolidesensit
strain
vs
p
zhou
et
al
manifest
includ
skin
diseas
nervou
system
complic
respect
mrmpinfect
children
serum
inflammatori
cytokin
level
higher
patient
infect
mrmp
patient
infect
macrolidesensit
strain
matsuda
et
al
suggest
higher
persist
inflammatori
stimul
mrmp
may
increas
possibl
sever
lung
lesion
extrapulmonari
complic
previou
attempt
produc
vaccin
basi
inactiv
bacteria
result
limit
efficaci
cap
variou
advers
effect
linchevski
et
al
recent
use
recombin
protein
potenti
vaccin
found
promis
immun
mice
immunogen
recombin
protein
encompass
ctermin
part
protein
induc
strong
mucos
system
antibodi
respons
pneumonia
reduc
lung
inflamm
infect
mice
zhu
et
al
anoth
studi
show
immun
guinea
pig
chimer
protein
consist
adhes
protein
pneumonia
result
robust
antibodi
respons
led
reduct
bacteri
load
respiratori
tract
hausner
et
al
increas
preval
mrmp
becom
signific
issu
sinc
mrmp
potenti
caus
sever
even
extrapulmonari
diseas
symptom
radiolog
featur
pneumonia
cap
seem
unspecif
current
diagnost
procedur
discern
carriag
infect
clinic
relev
time
frame
simpl
clinic
rule
may
aid
physician
prescrib
appropri
firstlin
antibiot
thu
empir
macrolid
treatment
may
restrict
children
high
risk
pneumonia
cap
ie
children
cap
fever
day
year
age
case
sever
diseas
futur
research
focu
novel
aspect
pneumoniaerel
pathogenesi
result
precis
diagnost
tool
tailor
treatment
prevent
emerg
antimicrobi
resist
author
list
made
substanti
direct
intellectu
contribut
work
approv
public
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
